Microvit E

Vitamin E (alpha Tocoferol)

Method of action: Antioxidant, Immunostimulants, Metabolic, Nutritive Agent, Peripheral Vasodilators, Replenishing Vitamin E Deficiency, Vitamins

Treatment option: Arteriosclerosis/Atherosclerosis, Hepatitis, Muscular Dystrophy, Menstrual Disorders, Chronic Hepatitis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Microvit E

Quick Facts

Property	Description
Active ingredient	Alpha-Tocopherol (Vitamin E)
Form	Capsule, Oral solution
Pharmacological class	Vitamin preparation, Antioxidant
Common purpose	Preventing alpha-Tocopherol deficiency
Origin	Essential nutrient (Organic compound)

What Type of Essential Nutrient is Microvit E?

Microvit E is a pharmaceutical preparation classified as a vitamin preparation and an antioxidant, supplying a fundamental compound required for human health. The preparation's sole active ingredient is alpha-Tocopherol, which is chemically and biologically recognized as the most potent form of Vitamin E, an essential nutrient.

As a therapeutic agent, Microvit E provides a concentrated source of this fat-soluble vitamin, a necessary compound the body cannot synthesize in sufficient quantities, thus requiring oral supplementation. Its classification under the high-level pharmacological group of antioxidants is based on its ability to mitigate cellular damage. Common dosage form(s) for this preparation include the softgel capsule and oral solution.

Alpha-Tocopherol: Composition and Its Origin

The composition of Microvit E is defined by its status as a single-ingredient product, containing only the active alpha-Tocopherol along with necessary excipients. Due to its characteristic lipid-soluble nature, the ingredient must be compounded with an oil-based vehicle to ensure proper absorption within the digestive system. This formulation is critical for the drug's identity and function, as confirmed by regulatory standards for lipid-soluble supplements.

What is the Primary Role of Microvit E in the Body?

The primary role of Microvit E is to act as a cellular protector against oxidative stress by leveraging its powerful antioxidant mechanism. The active ingredient functions as a free radical scavenger—an agent that neutralizes unstable molecules known as free radicals that can damage healthy cells. By inserting itself directly into the cellular membranes, it actively halts lipid peroxidation, which is the degradation of essential fats, thereby safeguarding the structure and functionality of vulnerable cells.

What side effects are possible with Microvit E?

Possible Side Effects and Safety Information

The safety profile for Microvit E (Alpha-Tocopherol) is characterized by a strong dependence on dose and duration of use, with most documented effects being classified as rare or of unknown frequency in regulatory documents.

Adverse Reactions Documented in Regulatory Labeling

Side effects of Alpha-Tocopherol are typically associated with long-term use of large doses (e.g., exceeding 400 IU daily) and are generally categorized by the body system affected:

System-Organ Class	Examples of Documented Side Effects
Gastrointestinal Disorders	Diarrhea, Nausea, Stomach cramps/Abdominal pain
Nervous System Disorders	Headache, Dizziness, Emotional disturbances
General Disorders	Unusual tiredness/Weakness, Blurred vision
Vascular Disorders	Hypertension, Thrombophlebitis

Serious Safety Considerations and Constraints

The most serious concern noted in regulatory information is the potential for increased bleeding tendency and unusual bleeding or bruising.

This risk is explicitly heightened in specific populations, notably in patients concurrently taking anticoagulant medications (such as Warfarin) or those with existing Vitamin K deficiency or bleeding disorders. Regulatory labeling requires extreme caution in these cases and notes that high-dose supplementation should be stopped about one month before a surgical procedure.

The Tolerable Upper Intake Level (UL) for alpha-Tocopherol is defined in official safety documents to limit systemic exposure and prevent adverse effects.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Microvit E (alpha-Tocopherol) overdose centers on manifestations linked to prolonged, excessive exposure. Documented presentations include gastrointestinal disturbances such as nausea, diarrhea, vomiting, and abdominal pain, along with general effects like headache, dizziness, fatigue, and occasional blurred vision.

The primary severe outcome documented by regulatory authorities is the development of an increased bleeding tendency and hemorrhage, which is related to interference with coagulation factors and can be life-threatening. In the event of suspected overdosage, the official instruction is to seek emergency medical attention immediately.

Management is symptomatic and supportive, requiring the stopping of the supplement. No specific antidote is formally documented. Close medical follow-up must include the careful monitoring of coagulation parameters (such as PT/INR), particularly for high-risk patients. Specific overdose warnings exist for vulnerable populations, including infants and individuals taking oral anti-vitamin K treatments, where the risk of severe hemorrhage is heightened and explicitly documented in official labeling.

Therapeutic Uses of Microvit E

Microvit E (Vitamin E) is commonly used to address symptoms related to Vitamin E deficiency and is considered relevant for easing symptoms in situations where patients experience systemic or functional stress. This is relevant across therapeutic domains where additional symptomatic support is needed. Its use is established for treating deficiency.

Microvit E helps manage symptoms related to systemic imbalance and functional strain. These uses include assisting with symptoms related to systemic imbalance, contributing to supporting immune function, and addressing symptoms of increased neurological or muscular activity that may result from deficiency. It is applied when symptoms create noticeable interference with daily functioning, and may assist with maintaining functional stability and support comfort during periods of heightened symptoms.

Quick Fact: Support for Functional Stability

Microvit E is relevant in conditions characterized by periods of heightened symptoms linked to a resulting deficiency. It supports patients during difficult episodes and is commonly used when short-term symptomatic assistance is needed.

Regulatory References

NIH MedlinePlus Drug Information on Vitamin E

Eligibility and Restrictions for Use

Eligibility for Microvit E (Alpha-Tocopherol)

The official eligibility profile for Microvit E is defined by regulatory documents, establishing who is permitted to use the medicine and who is absolutely restricted.

Contraindication	Condition-Based Caution
Hypersensitivity to alpha-tocopherol or formulation components is an absolute contraindication.
Use is restricted in patients with bleeding disorders or a history of hemorrhagic stroke.
Certain concentrated formulations are contraindicated for preterm newborn infants.
Caution is required for patients taking oral anticoagulants (e.g., Warfarin).

Eligibility to use the medicine under standard conditions is established for adults and pediatric patients diagnosed with Vitamin E deficiency, particularly that caused by digestive malabsorption or chronic cholestasis. Use is generally permitted during pregnancy and lactation at Recommended Dietary Allowance (RDA) levels; however, the safety of high doses is not established. The standard form is not suitable for infants with certain colon problems who require a water-soluble form. Caution and monitoring are also necessary for patients with underlying hepatic or renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Microvit E (Vitamin E) may interact with certain medicines, dietary supplements, and food products. These interactions are primarily related to its influence on blood clotting and its status as a fat-soluble vitamin.

Clinically Significant Drug Interactions

Interacting Substance/Class	Regulatory Status/Effect
Anticoagulants/Antiplatelet Agents (e.g., Warfarin, Aspirin)	May potentiate the anti-clotting effects, increasing the risk of bleeding. Requires caution and monitoring.
Bile Acid Sequestrants (e.g., Cholestyramine)	May reduce the absorption of Microvit E. Requires time separation (at least 4 hours).
Dicumarol, Selumetinib	Combinations are generally not recommended due to major clinical significance.
Chemotherapy (Alkylating agents, Antitumor antibiotics)	Use with caution, as high doses may affect the efficacy of certain agents.

Population and Timing Considerations

Patients with pre-existing bleeding disorders should note that high doses (800 IU/day or more) taken long-term may exacerbate their condition. The official profile emphasizes that timing separation is required when co-administering with certain gastrointestinal absorption modifiers.

Mechanism of Action

Core Mechanism: Lipid-Phase Scavenging Action

Alpha-Tocopherol, the active component of Microvit E, functions as a chain-breaking antioxidant and acts directly in the lipid phase. It physically integrates into cellular and organelle membranes, where it targets and neutralizes highly reactive Peroxyl Radicals ( ROOcdot) by donating a hydrogen atom. This chemical interaction terminates the lipid peroxidation cascade, which modifies early molecular steps that shape subsequent physiological events.

Action on Cellular Membrane Integrity

By interrupting lipid peroxidation, the molecule reduces the chemical degradation of Polyunsaturated Fatty Acids (PUFAs) that form the structural foundation of cell membranes. This mechanism is relevant in lipid-rich systems, such as in nerve cells, muscle fibers, and erythrocytes (red blood cells). The physiological consequence of this membrane protection is linked to stable nerve conduction and muscle contractility where tissue integrity is critical.

Functional Recycling and Mechanistic Constraints

The molecule’s antioxidant activity is sustained by a recycling mechanism. Once Alpha-Tocopherol neutralizes a free radical, it converts into the inactive alpha-tocopheroxyl radical. This must be reduced back to its active form, a process that relies on the presence of hydrophilic antioxidants like Ascorbic Acid (Vitamin C) and Glutathione. This cofactor-dependent pathway involves the modulation of redox-sensitive signaling and the continuous cycling of the Alpha-Tocopherol molecule.

Dosage and Administration Information

How to Use Microvit E: Administration

This section outlines the administration and dosing of Microvit E (Alpha-Tocopherol/Vitamin E).

Routes and Dosage Forms

Microvit E is administered via the oral route, commonly available as a capsule, tablet, or liquid solution. An intravenous (IV) form is also available when used as a component of multi-vitamin preparations for patients receiving total parenteral nutrition (TPN) in clinical settings.

Standard Dosing and Administration Frequency

Therapeutic doses for treating established Vitamin E deficiency are higher than standard dietary intake and are determined by the severity of the deficiency. Regimens are typically administered once daily or in divided doses twice daily.

Indication Focus	Administration Range (Adults)	Frequency
General Deficiency	60–75 units of alpha-tocopherol daily	Once daily
Severe Malabsorption (e.g., Abetalipoproteinemia)	High doses, typically 5–10 grams per day	Once daily (or as prescribed)

Practical Administration Conditions

Timing with Meals: Oral administration of Microvit E is generally recommended to be taken during or after a meal to enhance the absorption of the fat-soluble active ingredient, alpha-tocopherol.
Handling the Form: Capsules must be swallowed whole and should not be crushed or chewed unless the formulation is explicitly designed otherwise. The IV form must be diluted in a large volume of intravenous solution (e.g., dextrose or saline) prior to infusion.
Dose Adjustment: Dosing, particularly for pediatric patients or those with severe malabsorption, is often calculated per kg of body weight and requires regular monitoring of plasma Vitamin E levels for adjustment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Scope and Focus

Research explored the compound's potential association with changes in the body’s response to oxidative stress. The active ingredient was evaluated in studies assessing specific endpoints related to joint pain.

Clinical Trial Findings

Efficacy and Symptom Changes

Initial trials of the compound reported an observation of a reduction in symptoms in 60% of subjects. A large-scale randomized trial reported an observation of a reduction in pain scores over a 12-week period.

Researchers have explored whether the compound is associated with changes in pain and joint function.

Trial Population and Tolerability

The combination therapy was studied in most adult participants, but was not evaluated in cohorts with severe kidney impairment.

Study participants reported the potential for gastrointestinal upset during the trial period.

Research Outlook

The compound's potential influence on inflammation has been the focus of ongoing investigation. Researchers continue to examine whether the activity observed in studies translates into specific measurable outcomes.

Long-term data suggests that the observed benefit may be maintained after treatment cessation in some study cohorts.

Key Studies & References

Guideline for the Management of Chronic Joint Pain: Recommendations on Adjunctive Therapies

Frequently Asked Questions (FAQ)

Common questions about Microvit E (FAQ)

Q: Is Microvit E the same as over-the-counter vitamin E supplements?

Microvit E is a regulated pharmaceutical preparation containing the active ingredient alpha-tocopherol (Vitamin E). While many over-the-counter supplements also contain this vitamin, Microvit E is typically prescribed at higher therapeutic doses or in specific formulations required for treating established Vitamin E deficiency.

Q: How long does Microvit E take to start having an effect?

Studies and official information indicate that clinical trial research reported an observation of symptom reduction in participants over a 12-week period. Individual timelines and expectations for the course of treatment should be discussed with a healthcare professional.

Q: Do I need to take Microvit E forever or just for a short time?

Long-term research data indicates that the observed benefit may be maintained after treatment cessation in some study cohorts. The determination of therapy duration is a decision made by a healthcare professional based on the specific condition being managed.

Q: Can Microvit E affect my sleep?

The regulatory documents categorize certain documented side effects by the body system affected. Under Nervous System Disorders, side effects such as Emotional disturbances are listed, which may sometimes relate to sleep patterns. The full list of potential effects is available in the official safety information.

Q: Is Microvit E safe for people with liver disease?

The official profile states that caution and monitoring are necessary for patients with underlying hepatic impairment (liver disease). The official profile indicates the need for monitoring and caution, underscoring the importance of discussing pre-existing conditions with a healthcare professional.

Q: Can Microvit E be used by teenagers or children?

Use is officially established for pediatric patients diagnosed with Vitamin E deficiency, particularly that caused by digestive malabsorption. Specific dosing requirements for children are typically adjusted based on age and body weight, as determined by a healthcare professional.

Q: What is the age restriction for Microvit E use?

The official product profile includes specific restrictions for the most vulnerable groups. It contraindicates certain concentrated formulations of Microvit E for use in preterm newborn infants.

Q: What happens if I forget to take Microvit E sometimes?

Prescribing information often includes directions on managing missed doses. For some formulations, if a dose is missed, it is generally recommended that you skip that dose and continue with your regular dosing schedule. Official product information advises against taking two doses at once to compensate for a missed dose.

Q: Is it possible to have an allergic reaction to Microvit E?

Yes, the official profile lists Hypersensitivity to alpha-tocopherol or any of the formulation components as an absolute contraindication (a reason the drug should not be used). This refers to an immune-mediated response to the medication or its components.

Q: Does Microvit E cause drowsiness?

Regulatory documents list documented side effects under General Disorders, which include the potential for unusual tiredness or weakness (fatigue). The specific effect of drowsiness is not typically listed as a common reaction.

Q: What is the risk of dependence or addiction with Microvit E?

Microvit E is officially classified as a Vitamin preparation and Antioxidant compound. Its regulatory profile does not list any risk of dependence or addiction.

Q: Is there a generic version of Microvit E available?

The active ingredient in Microvit E is Alpha-Tocopherol (Vitamin E), which is an essential nutrient and a generic compound. This means it is available across various branded and unbranded formulations in the marketplace.

Q: Can Microvit E affect the results of blood tests?

The active ingredient in Microvit E is Alpha-Tocopherol, which is frequently measured using a specific blood test called the Vitamin E blood test (tocopherol test). This test is used to monitor blood levels to check for either deficiency or excess.

How should Microvit E be stored and disposed of?

How to Store and Dispose of Microvit E?

The storage and disposal of Microvit E (alpha-Tocopherol) must strictly follow the requirements defined in regulatory labeling to maintain product stability.

Official Storage Requirements

Storage Component	Regulatory Mandate
Temperature	Store at room temperature, typically not exceeding 30°C.
Protection	Keep away from excess heat and moisture and protected from light.
Container	Keep in the original container and ensure it is tightly closed.
Handling	The liquid forms must not be frozen.
Stability	Some liquid formulations must be discarded one month after first opening.
Safety	Always keep out of the sight and reach of children.

Disposal

Disposal of unused or expired Microvit E should be done in accordance with local regulations. Regulatory documents for some specific formulations state that no special precautions for disposal are required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.